Medistim ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	206.85	134.25	135.21	146.05	90.9
Depreciation & Amortization	16.02	24.51	23.66	23.29	23.43
Stock-Based Compensation	-	1.07	6.01	-	-
Other Adjustments	-	-	-	-	23.17
Change in Receivables	-	5.32	27.35	-33.02	-11.15
Changes in Inventories	-	-15.13	-31.06	-16.92	15.25
Changes in Accounts Payable	-	1.95	0.61	11.27	-0.32
Changes in Income Taxes Payable	-28.34	-28.4	-25.7	-19.17	-13.34
Changes in Other Operating Activities	-2.95	19.54	-16.89	2	-0.57
Operating Cash Flow	191.57	143.1	119.2	113.49	127.37
Operating Cash Flow Growth	33.87%	20.06%	5.03%	-10.90%	71.82%
Capital Expenditures	-	-6.07	-16.4	-9.25	-7.4
Purchases of Intangible Assets	-	-18.63	-13.33	-11.85	-4.08
Investing Cash Flow	-36	-24.69	-29.73	-21.1	-11.49
Long-Term Debt Repaid	-	-	-	-	-4.5
Net Long-Term Debt Issued (Repaid)	-	-	-	-	-4.5
Repurchase of Common Stock	-4.41	-	-	-	-
Net Common Stock Issued (Repurchased)	-4.41	-	-	-	-
Common Dividends Paid	-109.47	-82.41	-82.18	-68.4	-54.64
Other Financing Activities	-8.81	-9.12	-8.71	-1.91	0.09
Financing Cash Flow	-122.69	-91.53	-90.89	70.3	-59.05
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-	-1.54	2.65	1.07	0.76
Net Cash Flow	32.88	25.34	1.23	23.15	57.6
Free Cash Flow	191.57	137.04	102.8	104.24	119.97
Free Cash Flow Growth	39.80%	33.30%	-1.38%	-13.11%	79.91%
FCF Margin	27.38%	24.36%	19.53%	21.19%	28.08%
Free Cash Flow Per Share	10.48	7.48	5.62	5.70	6.57
Levered Free Cash Flow	143.93	100.23	38.05	105.19	103.45
Unlevered Free Cash Flow	135.73	97.78	35.15	101.44	109.71

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.